# Extended-Release vs. Oral Naltrexone Alcohol Treatment in Primary Care

> **NCT01893827** · PHASE4 · COMPLETED · sponsor: **NYU Langone Health** · enrollment: 237 (actual)

## Conditions studied

- Alcohol Dependence

## Interventions

- **DRUG:** XR-NTX (Extended-Release Naltrexone)
- **DRUG:** Oral Naltrexone (O-NTX)

## Key facts

- **NCT ID:** NCT01893827
- **Lead sponsor:** NYU Langone Health
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-06
- **Primary completion:** 2018-10-03
- **Final completion:** 2018-10-03
- **Target enrollment:** 237 (ACTUAL)
- **Last updated:** 2020-06-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01893827

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01893827, "Extended-Release vs. Oral Naltrexone Alcohol Treatment in Primary Care". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01893827. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*